上海谊众：2025年净利同比预增760.18%~903.54%

Core Viewpoint - Shanghai Yizhong (688091.SH) expects a significant increase in net profit for the fiscal year 2025, projecting a range of 60 million to 70 million yuan, representing a growth of 760.18% to 903.54% compared to the previous year [2] Group 1: Financial Performance - The projected net profit for 2025 is between 60 million and 70 million yuan [2] - This represents a substantial increase of 760.18% to 903.54% year-over-year [2] Group 2: Business Drivers - The core product, paclitaxel micelles, is expected to be included in the national medical insurance catalog in 2025 [2] - The inclusion in the insurance catalog is anticipated to significantly increase market access and the number of patients using the product, leading to substantial revenue and profit growth [2]